Congress trades in Madrigal Pharmaceuticals (MDGL)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Madrigal Pharmaceuticals (MDGL) since 2023: 0 buys and 1 sale. The most recent was disclosed on May 19, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Who traded MDGL
MemberBuysSalesLast disclosed
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01May 19, 2023
All trades
DisclosedTradeAmount
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Madrigal Pharmaceuticals MDGL
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.